MiniMed Group Regulatory Approval
MiniMed Group received FDA clearance for its MiniMed Fit™ patch pump, the company's first tubeless insulin pump, several months ahead of schedule. The approval triggers a $162 million one-time R&D payment obligation and has led the company to accelerate its U.S. commercial launch to Spring 2027.